Morbillivirus infection of the mouse central nervous system induces region-specific upregulation of MMPs and TIMPs correlated to inflammatory cytokine expression

Journal of Virology

Volumn 75, Issue 17, 2001, Pages 8268-8282

  Khuth, S T ^a   Akaoka, H ^a   Pagenstecher, A ^a   Verlaeten, O ^a   Belin, M F ^a   Giraudon, P ^a   Bernard, A ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; MATRIX METALLOPROTEINASE; MESSENGER RNA; TISSUE INHIBITOR OF METALLOPROTEINASE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CENTRAL NERVOUS SYSTEM INFECTION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; FEMALE; HIPPOCAMPUS; HYPOTHALAMUS; INFLAMMATION; MEASLES VIRUS; MONOAMINERGIC SYSTEM; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; SPINAL CORD; TH1 CELL; VIRUS REPLICATION;

ANIMALS; BRAIN; CYTOKINES; DISEASE MODELS, ANIMAL; DISTEMPER; DISTEMPER VIRUS, CANINE; DOGS; FEMALE; GENE EXPRESSION REGULATION, VIRAL; HUMANS; METALLOENDOPEPTIDASES; MICE; PROTEASE INHIBITORS; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASE-1; TISSUE INHIBITOR OF METALLOPROTEINASE-3; UP-REGULATION; VIRUS REPLICATION;

EID: 0034864814     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.17.8268-8282.2001     Document Type: Article

References (68)

1. Matrix metalloproteinase-9 (MMP-9) is synthesized in neurons of the human hippocampus and is capable of degrading the amyloid-beta peptide (1-40)
2. Focalized proteolysis: Spatial and temporal regulation of extracellular matrix degradation at the cell surface
3. Inhibition of tyrosine hydroxylase expression within the substantia nigra of mice infected with canine distemper virus
4. Selective induction of cytokines in mouse brain infected with canine distemper virus: Structural, cellular and temporal expression
5. Neuronal IFN-gamma in tuberomammillary neurones. Co-induction of neuronal interferon-gamma and nitric oxide synthase in rat motor neurons after axotomy: A role in nerve repair or death?
6. Alteration of the leptin network in late morbid obesity induced in mice by brain infection with canine distemper virus
7. Brain structures selectively targeted by canine distemper virus in a mouse model infection
8. Canine distemper infection in mice; characterization of a neuro-adapted virus strain and its long-term evolution in the mouse
9. Identification of the interleukin-6/oncostatin M response element in the rat tissue inhibitor of metalloproteinases-1 (TIMP-1) promoter
10. Inhibitory cytokines and cytokine inhibitors
11. Altered ratios of measles virus transcripts in diseased human brains
12. Matrix metalloproteinases degrade myelin basic protein
13. Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia
14. The expression of tissue-type plasminogen activator, matrix metalloproteases and endogenous inhibitors in the central nervous system in multiple sclerosis: Comparison of stages in lesion evolution
15. Membrane-type matrix metalloproteinases 1 and 2 exhibit broad-spectrum proteolytic capacities comparable to many matrix metalloproteinases
16. The gene family encoding the mouse ribosomal protein L32 contains a uniquely expressed intron-containing gene and an unmutated processed gene
17. The roles of tissue inhibitors of metalloproteinases in tissue remodelling and cell growth
18. Gamma interferon is a major mediator of antiviral defense in experimental measles virus-induced encephalitis
19. Cytokines secreted by glial cells infected with HTLV-I modulate the expression of matrix metalloproteinases (MMPs) and their natural inhibitor (TIMPs): Possible involvement in neurodegenerative processes
20. Extracellular matrix-remodeling metalloproteinases and infection of the central nervous system with retrovirus human T-lymphotropic virus type I (HTLV-I)
21. T lymphocytes activated by persistent viral infection differentially modify the expression of metalloproteinases and their endogenous inhibitors, TIMPs, in human astrocytes: Relevance to HTLV-I-induced neurological disease
22. Induction of MMP9 (92 kDa gelatinase) activity and expression of tissue inhibitor of metalloproteinase-2 mRNA (TIMP-2) in primitive neuroectodermal cells infected with retrovirus HTLV-I
23. Matrix metalloproteinase 9 (gelatinase B) in cerebrospinal fluid of HTLV-I infected patients with tropical spastic paraparesis
24. Matrix metalloproteinases in immunity
25. Regulation of matrix metalloproteinase expressions in astrocytes, microglia and neurons
26. Cytokines regulate gelatinase A and B (matrix metalloproteinase 2 and 9) activity in cultured rat astrocytes
27. Tissue inhibitors of metalloproteinases and their cell growth-promoting activity
28. Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum
29. Neuronal excitation-driven and AP-1-dependent activation of tissue inhibitor of metalloproteinases-1 gene expression in rodent hippocampus
30. Matrix metalloproteinases MMP-9 and MMP-7 are expressed in experimental autoimmune neuritis and the Guillain-Barre syndrome
31. Differential expression of matrix metalloproteinases in bacterial meningitis
32. MT-MMP, the cell surface activator of proMMP-2 (progelatinase A), is expressed with its substrate in mouse tissue during embryogenesis
33. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in viral meningitis: Upregulation of MMP-9 and TIMP-1 in cerebrospinal fluid
34. Tissue inhibitor of metalloproteinase 3, matrix metalloproteinase 9, and neopterin in the cerebrospinal fluid: Preferential presence in HTLV type I-infected neurologic patients versus healthy virus carriers
35. Matrix metalloproteinases in the neocortex and spinal cord of amyotrophic lateral sclerosis patients
36. Proteolytic action of thrombin is required for electrical activity-dependent synapse reduction
37. Synergistic transcriptional activation of the tissue inhibitor of metalloproteinases-1 promoter via functional interaction of AP-1 and Ets-1 transcription factors
38. Structural analysis and promoter characterization of the human membrane-type matrix metalloproteinase-1 (MT1-MMP) gene
39. ECM signalling: Orchestrating cell behaviour and misbehaviour
40. Extracellular matrix degradation by metalloproteinases and central nervous system diseases
41. Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions
42. The matrix-degrading metalloproteinases
43. Metalloproteinases and their inhibitors in matrix remodeling
44. Proteolysis and cell migration: Creating a path?
45. TIMP-2 growth-stimulatory activity: A concentration- and cell type-specific response in the presence of insulin
46. Extracellular space structure revealed by diffusion analysis
47. RNAse protection assays for the simultaneous and semiquantitative analysis of multiple murine matrix metalloproteinase (MMP) and MMP inhibitor mRNAs
48. Differential expression of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase genes in the mouse central nervous system in normal and inflammatory states
49. Regulation of matrix metalloproteinases and their inhibitor genes in lipopolysaccharide-induced endotoxemia in mice
50. Furin-dependent intracellular activation of the human stromelysin-3 zymogen
51. Transmembrane-deletion mutants of the membrane-type matrix metalloproteinase-1 process progelatinase A and express intrinsic matrix-degrading activity
52. Leukocyte gelatinase B cleavage releases encephalitogens from human myelin basic protein
53. Cytokine regulation of matrix metalloproteinase activity and its regulatory dysfunction in disease
54. Tissue inhibitor of metalloproteinases-1 (TIMP-1) is differentially induced in neurons and astrocytes after seizures: Evidence for developmental, immediate early gene, and lesion response
55. Sequence homology within the morbilliviruses
56. Glyceraldehyde-3-phosphate dehydrogenase mRNA is a major interleukin 2-induced transcript in a cloned T-helper lymphocyte
57. Activation of a recombinant membrane type 1-matrix metalloproteinase (MT1-MMP) by furin and its interaction with tissue inhibitor of metalloproteinases (TIMP)-2
58. Diffusion constraints and neuron-glia interaction during aging
59. Cytokine-induced endogenous procollagenase stored in the extracellular matrix of soft connective tissue results in a burst of collagen breakdown following its activation
60. ECM and cell surface proteolysis: Regulating cellular ecology
61. The soluble catalytic domain of membrane type 1 matrix metalloproteinase cleaves the propeptide of progelatinase A and initiates autoproteolytic activation. Regulation by TIMP-2 and TIMP-3
62. Comparative aspects of pathogenicity of measles, canine distemper, and rinderpest viruses
63. Matrix metalloproteinases and diseases of the CNS
64. The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1
65. Regional and differential expression of gelatinases in rat brain after systemic kainic acid or bicuculline administration
66. Zymographic measurement of gelatinase activity in brain tissue after detergent extraction and affinity-support purification
67. Cell cycle-associated accumulation of tissue inhibitor of metalloproteinases-1 (TIMP-1) in the nuclei of human gingival fibroblasts